Delivery Order HHSN261201200035I-HHSN26100007
Award Date 9/17/15
Potential Completion Date 10/21/20
Potential Value $1.1M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Evanston, IL 60208, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
7
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with a ceiling value of $1,159,347.10, was issued by the National Cancer Institute (NCI) to Northwestern University. The contract is part of the NCI's "Cancer Prevention Agent Development Program: Early Phase Clinical Research" and involves a Phase IIB clinical trial to evaluate the efficacy of topical 4-hydroxytamoxifen versus oral tamoxifen in treating ductal carcinoma in situ (DCIS) of the breast. Northwestern University is the prime contractor, and...
- This is a federal contract award from the National Cancer Institute (NCI) to Northwestern University, a private research university, for a Phase I clinical trial to evaluate the dermal tolerability and safety of an endoxifen gel in women undergoing breast surgery. The contract, which is part of NCI's Cancer Prevention Agent Development Program, has a ceiling value of $481,539.10 and a period of performance through August 31, 2023. Northwestern University is the prime contractor, with...
- This is a federal contract award from the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), to Northwestern University. The contract is titled "CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH" and is a delivery order under the "Cancer Prevention Agent Development Program 2012-2017" indefinite delivery vehicle (IDV). The contract has a ceiling value of $2,031,555.74 and a period of...
- This federal contract award from the National Cancer Institute (NCI), part of the Department of Health and Human Services, is for a clinical research study to evaluate the efficacy of intermittent dosing of aspirin for colorectal cancer prevention. The prime contractor is Northwestern University, a private research university, which has been awarded this $1,057,268.80 task order under the NCI's "Cancer Prevention Agent Development Program 2012-2017" indefinite delivery contract. The...
- This is a federal contract award from the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Northwestern University. The $3,544,085.97 contract is part of the Cancer Prevention Agent Development Program and provides core infrastructure support for early-phase clinical research. The contract is a delivery order under a larger IDV (Indefinite Delivery Vehicle) contract titled "Cancer Prevention Agent Development Program 2012-2017"....
- This federal contract award, with a ceiling value of $826,870.34, was issued by the National Cancer Institute (NCI) to Northwestern University for a Phase I clinical trial of inhaled iloprost to prevent lung cancer in former smokers. The award is part of the NCI's Cancer Prevention Agent Development Program, which supports early-phase research to evaluate novel cancer prevention agents. Northwestern University, a private research university, is serving as the prime contractor for this work....
- This federal contract award, issued by the National Cancer Institute, is for a Phase I single-arm, multicenter pilot study to validate Y-OHPDG as a biomarker and test the effects of Polyphenon E on its levels in patients with cirrhosis. The $1,410,682.11 contract was awarded to Northwestern University, which will serve as the prime contractor. Georgetown University and the University of Puerto Rico Medical Sciences Campus are listed as subcontractors. The contract is part of the National...
- This federal contract award with award ID HHSN261201500024I|HHSN26100003 was issued by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS). The $321,110.80 award was made on September 15, 2016 to the IIT Research Institute (IITRI), a non-profit research organization and division of the Illinois Institute of Technology (IIT). The contract is for the "PRECLINICAL EVALUATION OF A NEW LIPID-BASED SMEDDS" under the NCI's PREVENT...
- This $655,319.62 federal contract was awarded by the National Cancer Institute, which is part of the U.S. Department of Health and Human Services, to the University of Wisconsin System's division at the University of Wisconsin - Madison. The contract is for a Phase 1B clinical study to evaluate the biological effect of an early-stage breast cancer prevention agent. This award is part of the Cancer Prevention Agent Development Program, which supports early-phase clinical research. The contract...
- This is a prime contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of California Irvine (UC Irvine) for Phase I and II clinical trials of cancer chemopreventive agents. The $13,886,589.26 definitive contract does not have a set-aside designation, as UC Irvine was selected based on its extensive research capabilities and expertise in biomedical sciences. The contract supports the development of novel cancer prevention...